Search

Filters

Clear Filters
2:30 PM - 4:00 PM PT
11:05 AM - 11:15 AM PT

206 - Durable Survival and Updated Safety of TQB2450 plus Anlotinib Maintenance Therapy in Limited-Stage Small Cell Lung Cancer: Extended Follow-Up from a Prospective Phase Ib Trial

Speaker: Meng, Xiangjiao, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong
2:30 PM - 4:00 PM PT
2:30 PM - 4:00 PM PT
2:30 PM - 4:00 PM PT

2068 - Development of a Markerless Real-Time Monitoring Method for Radiation Therapy in Prostate Cancer

Speaker: Fujiwara, Toshiki, MD - Department of Radiation Oncology, Kochi University, Kochi, Kochi pref
2:30 PM - 4:00 PM PT